about
Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in miceFifty years of research on lipidsInhibition of PCSK9: a powerful weapon for achieving ideal LDL cholesterol levelsOxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosisThe influence of innate and adaptive immune responses on atherosclerosisOxidized phospholipids, Lp(a) lipoprotein, and coronary artery diseaseThe role of oxidized phospholipids in mediating lipoprotein(a) atherogenicityCEP Is an Important and Ubiquitous Oxidation Specific Epitope Recognized by Innate Pattern Recognition ReceptorsPolyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages.Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance.B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation.B-cell aortic homing and atheroprotection depend on Id3.Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice.Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase.The Effects of 2'-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials.Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish.Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humansB cells and humoral immunity in atherosclerosisT-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responsesApolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysisInterleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiencyModifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathwayYou are right too!Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemiaDeficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice.Oxidized cholesteryl esters and phospholipids in zebrafish larvae fed a high cholesterol diet: macrophage binding and activation.Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate dietC-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipidsAtheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccineAtherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress.4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice.Leucocyte telomere length and risk of type 2 diabetes mellitus: new prospective cohort study and literature-based meta-analysisImaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directionsVery-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.Research resource: Comparative nuclear receptor atlas: basal and activated peritoneal B-1 and B-2 cells.Reducing macrophage proteoglycan sulfation increases atherosclerosis and obesity through enhanced type I interferon signaling.The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE(-/-) miceOxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
P50
Q24647376-33FE4F60-B71C-430B-9892-2EF96A13CC97Q24652933-C2E9A576-1586-4AE0-B9B8-057867BC42DAQ24658351-3DD58DAF-32E0-4637-8B26-023F65117457Q26822962-D3AAA5EA-87D6-4E3D-8FD6-AF755DB77175Q27000370-BE29BFEF-1B32-4209-BC2A-C2D0C59EA713Q28260195-F14E0B52-4A13-430D-B4EE-4B0EF5E97BF4Q28286359-946C677F-1AF2-4458-9B9D-CC3CAA0C04F9Q28391010-B2DAB391-112E-4E72-960F-107F1736123DQ28537901-86912234-288D-404D-AF15-953509AF4C0EQ30277362-1E0D5D98-F2B6-4F2D-9E64-6EF0E61F15D0Q30279171-577A2AFF-B789-41E1-A990-57942CE0F783Q30413616-327FEEB8-2CB4-4F26-8C83-E6DAC2285A41Q30422974-7B70F33E-2F60-446A-81F6-289EA841658CQ30434635-3CA52666-5312-4C80-9C38-4153937550B2Q30480611-BF2A7A6B-5165-41A5-9A0E-DBD6CC3E56CFQ33438876-55241806-A947-4A5C-BE4C-8E8016D9D110Q33561072-94548F6B-6811-4D7F-87D8-5E0D76407B81Q33709903-C3E65177-C9D9-4921-A9F4-91E886E6109EQ33750290-873583D1-7CB7-45EC-9131-17F75D5C7B8CQ33789638-51D6449D-CEB5-45D4-A3BC-0028552883DEQ33819043-A7A9B6B7-69A3-4272-9A57-06111F741540Q33831563-1A26190F-FAD5-446C-90A6-8366CB73F39BQ33881232-022AA60C-DAC2-4E00-A4A6-AC5CC39057C4Q33897803-02C8F4BE-2562-4FAC-ABFD-1C35D63936FBQ33905863-7342C1FE-A929-4638-AC3D-0975F6AC1E20Q33997331-8E0C44D2-68F5-4363-AC10-5093888063EDQ34082315-6E5D3CD7-EB2D-424D-AC5B-B639E22F3D43Q34186521-D5C0548D-15FD-4104-A1CE-29CDBD3408B0Q34188087-EC8B9F17-1D29-46C0-AEA5-CFBCB2C42371Q34191416-B4A58132-A128-45E9-9F55-6C96038446ACQ34238712-E6C68D7D-7B6C-46EF-88DC-0146F7740483Q34346809-CEE6072D-DC46-458F-8A5D-6A2615A704A5Q34421798-E7905F58-68CA-4B3E-8596-0B69D3FD3E99Q34497686-CF64B4F1-714B-40C8-92E8-30B9987D5245Q34518372-267C326A-28E3-487D-AC84-863C9059B91BQ34551430-618EE12D-6ECC-497C-A339-F0CA8D52A1A5Q34609943-3222D009-BF30-4876-88DD-7ABBFD0711C4Q34625670-4E675ACA-F1F6-4A93-9D66-08C95990A808Q34644753-71F6D47C-0762-4383-B077-CE32F20FA333Q34652323-1A611703-4201-4500-A2A6-F089FCC0217B
P50
name
Joseph L Witztum
@ast
Joseph L Witztum
@en
Joseph L Witztum
@es
Joseph L Witztum
@nl
type
label
Joseph L Witztum
@ast
Joseph L Witztum
@en
Joseph L Witztum
@es
Joseph L Witztum
@nl
prefLabel
Joseph L Witztum
@ast
Joseph L Witztum
@en
Joseph L Witztum
@es
Joseph L Witztum
@nl